142 related articles for article (PubMed ID: 33882103)
21. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells.
Shi G; Gao F; Jin Y
J Cell Physiol; 2011 Dec; 226(12):3190-6. PubMed ID: 21321941
[TBL] [Abstract][Full Text] [Related]
22. HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells.
Jin H; Park JY; Choi H; Choung PH
Tissue Eng Part A; 2013 Mar; 19(5-6):613-24. PubMed ID: 23013422
[TBL] [Abstract][Full Text] [Related]
23. Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer´s disease-like phenotype of a commonly used mouse model.
Cuadrado-Tejedor M; Ricobaraza AL; Torrijo R; Franco R; Garcia-Osta A
Curr Pharm Des; 2013; 19(28):5076-84. PubMed ID: 23448463
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase activity is necessary for oligodendrocyte lineage progression.
Marin-Husstege M; Muggironi M; Liu A; Casaccia-Bonnefil P
J Neurosci; 2002 Dec; 22(23):10333-45. PubMed ID: 12451133
[TBL] [Abstract][Full Text] [Related]
25. 4-phenylbutyric acid promotes migration of gastric cancer cells by histone deacetylase inhibition-mediated IL-8 upregulation.
Shi X; Gong L; Liu Y; Hou K; Fan Y; Li C; Wen T; Qu X; Che X
Epigenetics; 2020; 15(6-7):632-645. PubMed ID: 31814524
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferation.
Somanna NK; Valente AJ; Krenz M; McDonald KS; Higashi Y; Noda M; Chandrasekar B
Hypertens Res; 2016 Oct; 39(10):709-716. PubMed ID: 27278287
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
[TBL] [Abstract][Full Text] [Related]
28. 4-Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition-mediated HER3/HER4 up-regulation.
Shi X; Zheng C; Li C; Hou K; Wang X; Yang Z; Liu C; Liu Y; Che X; Qu X
Cell Biol Int; 2018 Jan; 42(1):53-62. PubMed ID: 28851073
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
Obier N; Uhlemann CF; Müller AM
Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
[TBL] [Abstract][Full Text] [Related]
30. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase as a new target for cancer chemotherapy.
Yoshida M; Furumai R; Nishiyama M; Komatsu Y; Nishino N; Horinouchi S
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S20-6. PubMed ID: 11587361
[TBL] [Abstract][Full Text] [Related]
32. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
[TBL] [Abstract][Full Text] [Related]
33. HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain.
Foti SB; Chou A; Moll AD; Roskams AJ
Int J Dev Neurosci; 2013 Oct; 31(6):434-47. PubMed ID: 23542004
[TBL] [Abstract][Full Text] [Related]
34. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Histone Deacetylases Prevents Cardiac Remodeling After Myocardial Infarction by Restoring Autophagosome Processing in Cardiac Fibroblasts.
Wang Y; Chen P; Wang L; Zhao J; Zhong Z; Wang Y; Xu J
Cell Physiol Biochem; 2018; 49(5):1999-2011. PubMed ID: 30235443
[TBL] [Abstract][Full Text] [Related]
36. Trichostatin A inhibits skeletal muscle atrophy induced by cigarette smoke exposure in mice.
Ding J; Li F; Cong Y; Miao J; Wu D; Liu B; Wang L
Life Sci; 2019 Oct; 235():116800. PubMed ID: 31472151
[TBL] [Abstract][Full Text] [Related]
37. Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line.
Kusaczuk M; Krętowski R; Bartoszewicz M; Cechowska-Pasko M
Tumour Biol; 2016 Jan; 37(1):931-42. PubMed ID: 26260271
[TBL] [Abstract][Full Text] [Related]
38. Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors.
Lu Q; Wang DS; Chen CS; Hu YD; Chen CS
J Med Chem; 2005 Aug; 48(17):5530-5. PubMed ID: 16107152
[TBL] [Abstract][Full Text] [Related]
39. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures.
Cho JS; Moon YM; Park IH; Um JY; Kang JH; Kim TH; Lee SH; Kang HJ; Lee HM
Am J Rhinol Allergy; 2013 Jan; 27(1):18-23. PubMed ID: 23406592
[TBL] [Abstract][Full Text] [Related]
40. Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts.
Schuetze KB; Stratton MS; Blakeslee WW; Wempe MF; Wagner FF; Holson EB; Kuo YM; Andrews AJ; Gilbert TM; Hooker JM; McKinsey TA
J Pharmacol Exp Ther; 2017 Apr; 361(1):140-150. PubMed ID: 28174211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
